IPOSchedule
EN
EnglishDeutschFrançais
2025 offering

Akston Biosciences IPO

Akston Biosciences develops and commercializes biopharmaceutical products for companion animals.

  • AXTN
  • NYSE American
  • United States
  • Healthcare
Filed 8 Oct 2025

Offering in progress. A listing date has not been announced, and proposed terms may change.

Last verified 14 Oct 2026

Company overview

Akston Biosciences website

The company is a pet biotechnology company. Its products are intended for cats, dogs, and other companion animals.

Company country
United States

Offering details

Base offering, before overallotment

Exchange
NYSE American
Ticker
AXTN
Shares offered
2,222,222
Shares after offering
12,285,919
New shares
2,222,222
Existing shares sold
0

IPO timeline

  1. Registration filed
  2. Proposed terms published

Filings and documents

Other IPO profiles

Industrials01

VME Companies

VME Companies provides engineering, procurement and construction services and modular process systems and equipment.

IPO valuation$276M – $345M
Filings Nasdaq Capital MarketIPO
Industrials02

Helio Corp /FL/

Helio Corporation is a holding company providing technology, engineering, and research and development services.

Listing valuation$29.5M – $36.8M
Filings Nasdaq Capital MarketUplisting
Healthcare03

Neuro Spectrum Insights

Neuro Spectrum Insights develops software to support autism diagnosis through MRI image analysis.

IPO valuation$60.4M – $75.4M
Filings NYSE AmericanIPO